Literature DB >> 2145735

Hypertensive heart disease: relationship of silent ischemia to coronary artery disease and left ventricular hypertrophy.

A P Yurenev1, V DeQuattro, R B Devereux.   

Abstract

ECG evidence of silent ischemia occurs commonly in patients with systemic hypertension, but its relationship to left ventricular hypertrophy (LVH), large-vessel coronary artery disease (CAD), and neurohumoral factors remains unclear. Accordingly we validated the results of the echocardiographic method used to measure left ventricular (LV) mass in the Soviet Union by comparison with necropsy measurements in 30 patients, and we examined the relationships in 46 men with essential hypertension among ST segment depression during ambulatory monitoring, exercise stress and transesophageal pacing (n = 38), and LV mass, catheterization evidence of CAD (n = 25), and neurohumoral factors (plasma catecholamines and platelet aggregability). Echocardiographic measurements of LV mass by both the Soviet and Penn methods were closely correlated with necropsy values (r = 0.78 and 90, respectively; both p less than 0.001). During ambulatory monitoring from 1 to 17 episodes of greater than or equal to 1 mm ST depression occurred in 26 of 46 (65%) patients with hypertension; ischemia was also provoked by exercise or pacing stress in most but not all of these patients (65% and 80%, respectively). Neither ST depression nor the occurrence of additional episodes of symptomatic angina was related to the presence of coronary obstruction at catheterization; patients with and without ST depression did not differ in age, blood pressure, or LV mass.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145735     DOI: 10.1016/0002-8703(90)90212-g

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

Review 1.  Genetic contributions to left ventricular hypertrophy.

Authors:  D K Arnett
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

2.  Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy.

Authors:  S D Pringle; F G Dunn; A C Tweddel; W Martin; P W Macfarlane; J H McKillop; A R Lorimer; S M Cobbe
Journal:  Br Heart J       Date:  1992-05

3.  Causative role of coronary microvessels for the development and progression of chronic myocardial lesions in spontaneously hypertensive rats (SHR).

Authors:  H J Herrmann; P Mühlig
Journal:  Basic Res Cardiol       Date:  1992 Sep-Oct       Impact factor: 17.165

4.  Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.

Authors:  Robert W W Biederman; Mark Doyle; Alistair A Young; Richard B Devereux; Eduardo Kortright; Gilbert Perry; Jonathan N Bella; Suzanne Oparil; David Calhoun; Gerald M Pohost; Louis J Dell'Italia
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

5.  Noctural dipping status and left ventricular hypertrophy: A cardiac magnetic resonance imaging study.

Authors:  Jonathan C L Rodrigues; Antonio Matteo Amadu; Amardeep Ghosh Dastidar; Iwan Harries; Amy E Burchell; Laura E K Ratcliffe; Emma C Hart; Mark C K Hamilton; Julian F R Paton; Angus K Nightingale; Nathan E Manghat
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-08       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.